Veena Vijayanathan, Thresia Thomas, Leonard H Sigal, T J Thomas
{"title":"Direct measurement of the association constant of HER2/neu antisense oligonucleotide to its target RNA sequence using a molecular beacon.","authors":"Veena Vijayanathan, Thresia Thomas, Leonard H Sigal, T J Thomas","doi":"10.1089/108729002320351548","DOIUrl":null,"url":null,"abstract":"<p><p>A molecular beacon approach was developed to directly determine the association constant of RNA-DNA hybrid formation. The molecular beacon was composed of a 15-nt loop structure containing the antisense sequence that can hybridize with the AUG translational start site of the HER2/neu gene, which is overexpressed in a significant proportion of breast, ovarian, and lung tumors. The equilibrium association constant (Ka) of DNA binding to the RNA oligonucleotide was 6.4 +/- 0.14 x 10(7) M(-1) in the presence of 150 mM NaCl at 22 degrees C. The free energy change (AG) associated with RNA-DNA hybrid formation was -10.7 kcal/mole. The melting temperature (Tm) of RNA-DNA hybrid was 64.4 degrees C +/- 1 degree C in the presence of 150 mM NaCl. The RNA-DNA hybrid was more stable than the corresponding DNA-DNA duplex in 150 mM NaCl, as judged by both Ka and Tm data. We also determined the Ka, deltaG, and Tm values of RNA-DNA and DNA-DNA duplex formation in the presence of three monovalent cations, Li+, K+, and Cs+. The feasibility of this method was also investigated using a phosphorothioate molecular beacon. The information generated through this new approach for thermodynamic measurements might be useful for the design of oligonucleotides for antisense therapeutics.</p>","PeriodicalId":7996,"journal":{"name":"Antisense & nucleic acid drug development","volume":"12 4","pages":"225-33"},"PeriodicalIF":0.0000,"publicationDate":"2002-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/108729002320351548","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antisense & nucleic acid drug development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/108729002320351548","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20
Abstract
A molecular beacon approach was developed to directly determine the association constant of RNA-DNA hybrid formation. The molecular beacon was composed of a 15-nt loop structure containing the antisense sequence that can hybridize with the AUG translational start site of the HER2/neu gene, which is overexpressed in a significant proportion of breast, ovarian, and lung tumors. The equilibrium association constant (Ka) of DNA binding to the RNA oligonucleotide was 6.4 +/- 0.14 x 10(7) M(-1) in the presence of 150 mM NaCl at 22 degrees C. The free energy change (AG) associated with RNA-DNA hybrid formation was -10.7 kcal/mole. The melting temperature (Tm) of RNA-DNA hybrid was 64.4 degrees C +/- 1 degree C in the presence of 150 mM NaCl. The RNA-DNA hybrid was more stable than the corresponding DNA-DNA duplex in 150 mM NaCl, as judged by both Ka and Tm data. We also determined the Ka, deltaG, and Tm values of RNA-DNA and DNA-DNA duplex formation in the presence of three monovalent cations, Li+, K+, and Cs+. The feasibility of this method was also investigated using a phosphorothioate molecular beacon. The information generated through this new approach for thermodynamic measurements might be useful for the design of oligonucleotides for antisense therapeutics.
采用分子信标法直接测定RNA-DNA杂交形成的关联常数。该分子信标由一个含有反义序列的15-nt环状结构组成,可以与HER2/neu基因的AUG翻译起始位点杂交,HER2/neu基因在乳腺、卵巢和肺部肿瘤中过表达。在22℃条件下,150 mM NaCl存在下,DNA与RNA寡核苷酸结合的平衡结合常数(Ka)为6.4 +/- 0.14 × 10(7) M(-1),与RNA-DNA杂交形成相关的自由能变化(AG)为-10.7 kcal/mol。在150 mM NaCl存在下,RNA-DNA杂交体的熔融温度Tm为64.4℃+/- 1℃。在150 mM NaCl条件下,RNA-DNA杂交种比相应的DNA-DNA双工更稳定。我们还测定了在Li+、K+和Cs+三种一价阳离子存在下RNA-DNA和DNA-DNA双链形成的Ka、deltaG和Tm值。并利用硫代磷酸酯分子信标研究了该方法的可行性。通过这种新的热力学测量方法产生的信息可能对设计用于反义治疗的寡核苷酸有用。